Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity

Clin Pharmacol Ther. 2014 Mar;95(3):253. doi: 10.1038/clpt.2013.219. Epub 2013 Nov 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Antineoplastic Agents / toxicity*
  • Catechol O-Methyltransferase / genetics*
  • Cisplatin / toxicity*
  • Female
  • Hearing Loss / chemically induced*
  • Humans
  • Male
  • Methyltransferases / genetics*

Substances

  • Antineoplastic Agents
  • Methyltransferases
  • Catechol O-Methyltransferase
  • Cisplatin